Literature DB >> 21060091

White matter hyperintensity volume is increased in small vessel stroke subtypes.

N S Rost1, R M Rahman, A Biffi, E E Smith, A Kanakis, K Fitzpatrick, F Lima, B B Worrall, J F Meschia, R D Brown, T G Brott, A G Sorensen, S M Greenberg, K L Furie, J Rosand.   

Abstract

OBJECTIVE: White matter hyperintensity (WMH) may be a marker of an underlying cerebral microangiopathy. Therefore, we hypothesized that WMH would be most severe in patients with lacunar stroke and intracerebral hemorrhage (ICH), 2 types of stroke in which cerebral small vessel (SV) changes are pathophysiologically relevant.
METHODS: We determined WMH volume (WMHV) in cohorts of prospectively ascertained patients with acute ischemic stroke (AIS) (Massachusetts General Hospital [MGH], n = 628, and the Ischemic Stroke Genetics Study [ISGS], n = 263) and ICH (MGH, n = 122).
RESULTS: Median WMHV was 7.5 cm³ (interquartile range 3.4-14.7 cm³) in the MGH AIS cohort (mean age 65 ± 15 years). MGH patients with larger WMHV were more likely to have lacunar stroke compared with cardioembolic (odds ratio [OR] = 1.87 per SD normally transformed WMHV), large artery (OR = 2.25), undetermined (OR = 1.87), or other (OR = 1.85) stroke subtypes (p < 0.03). These associations were replicated in the ISGS cohort (p = 0.03). In a separate analysis, greater WMHV was seen in ICH compared with lacunar stroke (OR = 1.2, p < 0.02) and in ICH compared with all ischemic stroke subtypes combined (OR = 1.34, p < 0.007).
CONCLUSIONS: Greater WMH burden was associated with SV stroke compared with other ischemic stroke subtypes and, even more strongly, with ICH. These data, from 2 independent samples, support the model that increasing WMHV is a marker of more severe cerebral SV disease and provide further evidence for links between the biology of WMH and SV stroke.

Entities:  

Mesh:

Year:  2010        PMID: 21060091      PMCID: PMC3033608          DOI: 10.1212/WNL.0b013e3181fc279a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

1.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

Authors:  W T Longstreth; T A Manolio; A Arnold; G L Burke; N Bryan; C A Jungreis; P L Enright; D O'Leary; L Fried
Journal:  Stroke       Date:  1996-08       Impact factor: 7.914

2.  Relation of leukoaraiosis to lesion type in stroke patients.

Authors:  A Hijdra; B Verbeeten; J A Verhulst
Journal:  Stroke       Date:  1990-06       Impact factor: 7.914

3.  The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage.

Authors:  Jonathan Rosand; Mark H Eckman; Katherine A Knudsen; Daniel E Singer; Steven M Greenberg
Journal:  Arch Intern Med       Date:  2004-04-26

4.  Genetic variation in white matter hyperintensity volume in the Framingham Study.

Authors:  Larry D Atwood; Philip A Wolf; Nancy L Heard-Costa; Joseph M Massaro; Alexa Beiser; Ralph B D'Agostino; Charles DeCarli
Journal:  Stroke       Date:  2004-05-13       Impact factor: 7.914

5.  White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke.

Authors:  Lewis H Kuller; W T Longstreth; Alice M Arnold; Charles Bernick; R Nick Bryan; Norman J Beauchamp
Journal:  Stroke       Date:  2004-06-03       Impact factor: 7.914

6.  Heritability of leukoaraiosis in hypertensive sibships.

Authors:  Stephen T Turner; Clifford R Jack; Myriam Fornage; Thomas H Mosley; Eric Boerwinkle; Mariza de Andrade
Journal:  Hypertension       Date:  2004-01-12       Impact factor: 10.190

7.  Interaction between hypertension, apoE, and cerebral white matter lesions.

Authors:  Frank-Erik de Leeuw; Florence Richard; Jan Cees de Groot; Cornelia M van Duijn; Albert Hofman; Jan Van Gijn; Monique M B Breteler
Journal:  Stroke       Date:  2004-04-01       Impact factor: 7.914

8.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

9.  Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study.

Authors:  Tom Jeerakathil; Philip A Wolf; Alexa Beiser; Joseph Massaro; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli
Journal:  Stroke       Date:  2004-06-24       Impact factor: 7.914

Review 10.  Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies.

Authors:  J K Lovett; A J Coull; P M Rothwell
Journal:  Neurology       Date:  2004-02-24       Impact factor: 9.910

View more
  70 in total

1.  Neuromarkers of the common angiotensinogen polymorphism in healthy older adults: A comprehensive assessment of white matter integrity and cognition.

Authors:  Lauren E Salminen; Peter R Schofield; Kerrie D Pierce; Yi Zhao; Xi Luo; Youdan Wang; David H Laidlaw; Ryan P Cabeen; Thomas E Conturo; David F Tate; Erbil Akbudak; Elizabeth M Lane; Jodi M Heaps; Jacob D Bolzenius; Laurie M Baker; Lee M Cagle; Robert H Paul
Journal:  Behav Brain Res       Date:  2015-08-28       Impact factor: 3.332

Review 2.  Clinical neurogenetics: stroke.

Authors:  Natalia S Rost
Journal:  Neurol Clin       Date:  2013-07-17       Impact factor: 3.806

3.  Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage.

Authors:  Daniel Woo; Guido J Falcone; William J Devan; W Mark Brown; Alessandro Biffi; Timothy D Howard; Christopher D Anderson; H Bart Brouwers; Valerie Valant; Thomas W K Battey; Farid Radmanesh; Miriam R Raffeld; Sylvia Baedorf-Kassis; Ranjan Deka; Jessica G Woo; Lisa J Martin; Mary Haverbusch; Charles J Moomaw; Guangyun Sun; Joseph P Broderick; Matthew L Flaherty; Sharyl R Martini; Dawn O Kleindorfer; Brett Kissela; Mary E Comeau; Jeremiasz M Jagiella; Helena Schmidt; Paul Freudenberger; Alexander Pichler; Christian Enzinger; Björn M Hansen; Bo Norrving; Jordi Jimenez-Conde; Eva Giralt-Steinhauer; Roberto Elosua; Elisa Cuadrado-Godia; Carolina Soriano; Jaume Roquer; Peter Kraft; Alison M Ayres; Kristin Schwab; Jacob L McCauley; Joanna Pera; Andrzej Urbanik; Natalia S Rost; Joshua N Goldstein; Anand Viswanathan; Eva-Maria Stögerer; David L Tirschwell; Magdy Selim; Devin L Brown; Scott L Silliman; Bradford B Worrall; James F Meschia; Chelsea S Kidwell; Joan Montaner; Israel Fernandez-Cadenas; Pilar Delgado; Rainer Malik; Martin Dichgans; Steven M Greenberg; Peter M Rothwell; Arne Lindgren; Agnieszka Slowik; Reinhold Schmidt; Carl D Langefeld; Jonathan Rosand
Journal:  Am J Hum Genet       Date:  2014-03-20       Impact factor: 11.025

4.  Determinants of white matter hyperintensity burden in patients with Fabry disease.

Authors:  Natalia S Rost; Lisa Cloonan; Allison S Kanakis; Kaitlin M Fitzpatrick; Danielle R Azzariti; Virginia Clarke; Charles M Lourenco; Dominique P Germain; Juan M Politei; György A Homola; Claudia Sommer; Nurcan Üçeyler; Katherine B Sims
Journal:  Neurology       Date:  2016-04-20       Impact factor: 9.910

5.  Setting a gold standard for quantification of leukoaraiosis burden in patients with ischemic stroke: the Atherosclerosis Risk in Communities Study.

Authors:  Natalia S Rost; Saloomeh Sadaghiani; Alessandro Biffi; Kaitlin M Fitzpatrick; Lisa Cloonan; Jonathan Rosand; Dean K Shibata; Thomas H Mosley
Journal:  J Neurosci Methods       Date:  2014-01-15       Impact factor: 2.390

6.  Subclinical cerebrovascular disease inversely associates with learning ability: The NOMAS.

Authors:  Hilary Glazer; Chuanhui Dong; Mitsuhiro Yoshita; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco; Charles DeCarli; Yaakov Stern; Clinton B Wright
Journal:  Neurology       Date:  2015-05-22       Impact factor: 9.910

7.  Stroke: more than meets the eye--big consequences of small strokes.

Authors:  Natalia S Rost
Journal:  Nat Rev Neurol       Date:  2015-04-07       Impact factor: 42.937

8.  White matter hyperintensity volume correlates with matrix metalloproteinase-2 in acute ischemic stroke.

Authors:  Zachary A Corbin; Natalia S Rost; Svetlana Lorenzano; Walter N Kernan; Michael K Parides; Jeffrey B Blumberg; Paul E Milbury; Ken Arai; Sophia N Hartdegen; Eng H Lo; Steven K Feske; Karen L Furie
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-01-16       Impact factor: 2.136

9.  Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.

Authors:  Clinton B Wright; Nirav H Shah; Armando J Mendez; Janet T DeRosa; Mitsuhiro Yoshita; Mitchell S V Elkind; Ralph L Sacco; Charles DeCarli; Tatjana Rundek; Shonni Silverberg; Chuanhui Dong; Myles Wolf
Journal:  Stroke       Date:  2016-03-08       Impact factor: 7.914

10.  Prospectively Collected Cardiovascular Biomarkers and White Matter Hyperintensity Volume in Ischemic Stroke Patients.

Authors:  Pamela M Rist; Nancy R Cook; Julie E Buring; Kathryn M Rexrode; Natalia S Rost
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-02-22       Impact factor: 2.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.